CJ Corp.

Chief Medical Officer of BioTime's Subsidiary OncoCyte Corporation to Deliver Keynote Address at Fifth Chinese Congress on Stem Cell Therapy in Beijing, P.R. China.
Angiogenesis Weekly; 11/6/2009; 1283 words; ...blood plasma volume expander manufactured and distributed in the U.S. by Hospira, Inc. and in South Korea by CJ CheilJedang Corp. under exclusive licensing agreements. Additional information about BioTime can be found on the web at www.biotimeinc...

Other News To Note.
BIOWORLD Today; 11/4/2009; 2638 words; ...Berkeley, Calif., granted to CJ Corp., of Seoul, South Korea...human therapeutic uses. CJ will be responsible for obtaining...related costs and expenses. CJ has right of first refusal...sales royalties. o Cambrex Corp., East Rutherford, N...

Publication No. WO/2009/091228 Published on July 23, Assigned to Cj Cheiljedang for Guanosine Monophosphate Kinase Variant (South Korean Inventors)
US Fed News Service, Including US State News; 10/31/2009; 417 words; ...a guanosine monophosphate kinase variant having reduced gmp conversion activity. The patent has been assigned to Cj Cheiljedang Corp., Seoul, South Korea. According to an abstract posted by the World Intellectual Property Organization: "The...

CJ CheilJedang returns to profit in Q3.(Financial report)
YON - Yonhap News Agency of Korea; 10/30/2009; 464 words; SEOUL, Oct. 29 (Yonhap) -- CJ CheilJedang Corp., South Korea's biggest food and...loss of 25 billion won a year ago, CJ CheilJedang said. Revenue rose 9...to 118.2 billion won. Shares of CJ CheilJedang closed down 2.38 percent...

S KOREAN FOOD, DRUG MAKER CJ CHEILJEDANG RETURNS TO PROFIT IN Q3.(Financial report)
AsiaPulse News; 10/29/2009; 603 words; SEOUL, Oct 29 Asia Pulse - CJ CheilJedang Corp., South Korea's biggest food and...loss of 25 billion won a year ago, CJ CheilJedang said. Revenue rose 9...to 118.2 billion won. Shares of CJ CheilJedang closed down 2.38 per...